|
Castillo-González A.C., Nieto-Cerón S., Pelegrín-Hernández J.P., Montenegro M.F., Noguera J.A., López-Moreno M.F., Rodríguez-López J.N., Vidal C.J., Hellín-Meseguer D., Cabezas-Herrera J. Dysregulated cholinergic network as a novel biomarker of poor prognostic in patients with head and neck squamous cell carcinoma. BMC Cancer. 12 December 2015. 15. 10.1186/s12885-015-1402-y
AÑO: 2015; IF: 3.265
|
25956553
|
How CW, Teruel JA, Ortiz A, Montenegro MF, Rodríguez-López JN, Aranda FJ. Effects of a synthetic antitumoral catechin and its tyrosinase-processed product on the structural properties of phosphatidylcholine membranes. Biochim Biophys Acta. 2014 May;1838(5):1215-24. doi: 10.1016/j.bbamem.2014.01.025. Epub 2014 Feb 8. PubMed PMID: 24518157.
AÑO: 2014; IF: 3.411
|
|
Muñoz-Muñoz JL, García-Molina Mdel M, García-Molina F, Varon R, García-Ruiz PA, Rodríguez-López JN, García-Cánovas F. Indirect inactivation of tyrosinase in its action on 4-tert-butylphenol. J Enzyme Inhib Med Chem. 2014 Jun;29(3):344-52. doi: 10.3109/14756366.2013.782298. PubMed PMID: 23578311.
AÑO: 2014; IF: 2.332
|
|
García-Molina M., Muñoz Muñoz J., Martinez-Ortiz F., Martinez J., García-Ruiz P., Rodriguez-López J., García-Cánovas F. Tyrosinase-catalyzed hydroxylation of hydroquinone, a depigmenting agent, to hydroxyhydroquinone: A kinetic study. Bioorganic and Medicinal Chemistry. 1 July 2014. 22:3360-3369. 10.1016/j.bmc.2014.04.048
AÑO: 2014; IF: 2.793
|
|
Montenegro MF, Collado-González Mdel M, Fernández-Pérez MP, Hammouda MB, Tolordava L, Gamkrelidze M, Rodríguez-López JN. Promoting E2F1-mediated apoptosis in oestrogen receptor-?-negative breast cancer cells. BMC Cancer. 2014 Jul 26;14:539. doi: 10.1186/1471-2407-14-539. PubMed PMID: 25064027; PubMed Central PMCID: PMC4122786.
AÑO: 2014; IF: 3.362
|